Impact of voluntary folate fortification on plasma homocysteine and serum folate in Australia from 1995 to 2001: A population based cohort study

Journal of Epidemiology and Community Health

Volumn 59, Issue 5, 2005, Pages 371-376

  Hickling, Siobhan ^a   Hung, Joseph ^a   Knuiman, Matthew ^a   Jamrozik, Konrad ^a   McQuillan, Brendan ^a   Beilby, John ^a,b   Thompson, Peter ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

FOOD SUPPLEMENTATION;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; AUSTRALIA; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; FOLIC ACID BLOOD LEVEL; GENE; GENOTYPE; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; LIFESTYLE; MALE; MTHFR GENE; NORMAL HUMAN; POPULATION RESEARCH; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; COHORT STUDIES; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; FOOD, FORTIFIED; GENOTYPE; HOMOCYSTEINE; HOMOZYGOTE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; PLASMA; SERUM; SEX CHARACTERISTICS; WESTERN AUSTRALIA;

EID: 17644400183     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2004.027078     Document Type: Article

References (26)

1. National Health and Medical Research Council. Folate fortification. Report of the expert panel on folate fortification, (Endorsed at the 117th session of the NHMRC, Sydney, 1-2 Jun 1994). Canberra: Australian Government Publishing Service, 1995.
2. Commonwealth of Australia Gazette. Amendment no 27 to the Food Standards Code. Number GN 23, 14 Jun, 1995.
3. Webb K, Abraham B. Interim evaluation of the voluntary folate fortification policy. Canberra: Commonwealth Department of Health and Aged Care, 2001.
4. Bower C, Ryan A, Rudy E, et al. Trends in neural tube defects in Western Australia. Australian and New Zealand Journal of Public Health 2002;26:150.
5. Boushey CJ, Beresford SAA, Omenn GS. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995;274:1049-57.
6. Bautista LE, Arenas IA, Penuela A, et al. Total plasma homocysteine level and risk of cardiovascular disease. A meta-analysis of prospective cohort studies. J Clin Epidemiol 2002;55:882-7.
7. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202-6.
8. Jacques PF, Selhub J, Bostom AG, et al. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-54.
9. Malinow M, Duell P, Hess D, et al. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 1998;338:1009-15.
10. Riddell L, Chisnolm A, Williams S, et al. Dietary strategies for lowering homocysteine concentrations. Am J Clin Nutr 2000;71:1448-54.
11. Wald NJ, Law MR, Morris JK, et al. Quantifying the effect of folic acid. Lancet 2001;358:2069-73.
12. van Oort FV, Melse-Boonstra A, Brouwer IA, et al. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study. Am J Clin Nutr 2003;77:1318-23.
13. Lawrence MA, Rutishauser IHE, Lewis JL. An analysis of the introduction of folate-fortified food products into stores in Australia. Aust J Nutr Diet 1999;56:15-21.
14. Risk Factor Prevalence Study Management Committee. Risk factor prevalence study: survey no 3 1989. Canberra, Australia: National Heart Foundation and Australian Institute of Health, 1990.
15. McQuillan BM, Beilby JP, Nidorf M, et al. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening: the Perth carotid ultrasound disease assessment study (CUDAS). Circulation 1999;99:2383-8.
16. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with flouresence detection. J Chromatogr 1987;422:43-52.
17. Grant A, DeHoog S. Nutritional assessment and support. 3rd ed. Seattle: Anne Grant and Susan DeHoog, 1985.
18. Frosst P, Blom HJ, Milos R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-13.
19. Baghurst K, Record S. A computerised dietary analysis system for use with diet diaries or food frerquency questionnaires. Community Health Stud 1984;7:11-18.
20. Wheeler CE, Rutishauser IH, O'Dea K. Comparison of nutrient intake data from two food frequency questionnaires and weighed records. Aust J Nutr Diet 1995;52:140-8.
21. Hickling S, Knuiman M, Jamrozik K, et al. The development and validation of a rapid dietary assessment tool to determine folate intake. J Clin Epidemiol (in press).
22. Trewin D. Socio-economic indexes for areas, Australia 2001. Canberra: Australian Bureau of Statistics, 2003.
23. McLennan W, Podger A. National nutrition survey selected highlight Australia 1995. Canberra: Australian Bureau of Statistics, 1997.
24. Hirsch S, de la Maza P, Barrera G, et al. The Chilean flour folic acid fortification program reduces serum homocysteine levels and masks vitamin B-12 deficiency in elderly people. J Nutr 2002;132:289-91.
25. Ray JG, Vermeulen MJ, Boss SC, et al. Declining rate of folate insufficiency among adults following increased folic acid food fortification in Canada. Can J Public Health 2002;93:249.
26. Lancaster P, Hurst T. Trends in neural tube defects in Australia. Canberra: Commonwealth Department of Health and Aged Care, 2001.